Haleon commits £175M to first India plant, betting Pithampur becomes oral-care export hub

Sensodyne-maker Haleon will sink ₹2,000 crore into a Pithampur facility over 2-3 years, slashing import reliance as India climbs into its top 3-4 global markets. The bet rides on a GST cut from 18% to 5% and a target of 300 million consumers by 2030, squaring up against Colgate, Dabur and HUL.

— Source publishedMon, 8 Jun, 2026, 12:00 IST·First seen Mon, 8 Jun, 2026, 12:08 IST·Source Mint · Companies

What happened

Haleon will invest £175 million (₹2,000 crore) to build its first India oral health manufacturing plant in Pithampur, Madhya Pradesh, reducing import reliance

Key facts

  • £175 million
  • ₹2,000 crore
  • 71% share
  • £1.8 billion category
  • 300 million consumers by 2030
  • GST cut 18% to 5%

Why this matters

An export-hub thesis in a £1.8B category invites bolt-on oral-care or adjacency M&A around Pithampur, and raises the strategic premium on any Indian challenger brands Colgate or HUL might also chase.

Also reported by